These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19000546)

  • 21. [Tumor induced osteomalacia].
    Filipová L; Lazúrová I
    Vnitr Lek; 2021; 67(E-8):19-22. PubMed ID: 35459330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
    Ryhänen EM; Schalin-Jäntti C; Matikainen N
    Front Endocrinol (Lausanne); 2021; 12():686135. PubMed ID: 34149623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia.
    Jan de Beur SM; Minisola S; Xia WB; Abrahamsen B; Body JJ; Brandi ML; Clifton-Bligh R; Collins M; Florenzano P; Houillier P; Imanishi Y; Imel EA; Khan AA; Zillikens MC; Fukumoto S
    J Intern Med; 2023 Mar; 293(3):309-328. PubMed ID: 36511653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal Phosphate Wasting Due to Tumor-Induced (Oncogenic) Osteomalacia.
    Amaratunga EA; Ernst EB; Kamau J; Kotala R; Snyder R
    Cureus; 2021 Jun; 13(6):e15507. PubMed ID: 34268038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the thoracic spine.
    Pirola E; Vergani F; Casiraghi P; Leone EB; Guerra P; Sganzerla EP
    J Neurosurg Spine; 2009 Apr; 10(4):329-33. PubMed ID: 19441990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired hypophosphatemic osteomalacia associated with multiple myeloma.
    Narvaez J; Domingo-Domenech E; Narvaez JA; Nolla JM; Valverde J
    Joint Bone Spine; 2005 Oct; 72(5):424-6. PubMed ID: 16112595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Challenges in the management of tumor-induced osteomalacia (TIO).
    Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
    Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A paranasal tumor associated with tumor-induced osteomalacia.
    Inokuchi G; Tanimoto H; Ishida H; Sugimoto T; Yamauchi M; Miyauchi A; Nibu K
    Laryngoscope; 2006 Oct; 116(10):1930-3. PubMed ID: 17003734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
    Takeuchi Y; Suzuki H; Ogura S; Imai R; Yamazaki Y; Yamashita T; Miyamoto Y; Okazaki H; Nakamura K; Nakahara K; Fukumoto S; Fujita T
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3979-82. PubMed ID: 15292336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient].
    Dupond JL; Magy N; Mahammedi M; Prie D; Gil H; Meaux-Ruault N; Kantelip B
    Rev Med Interne; 2005 Mar; 26(3):238-41. PubMed ID: 15777586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L; Padala SA; Mohammed A; Belayneh N
    J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia.
    Khadgawat R; Singh Y; Kansara S; Tandon N; Bal C; Seith A; Kotwal P
    Singapore Med J; 2009 Feb; 50(2):e55-7. PubMed ID: 19296011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
    Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
    BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia.
    Higley M; Beckett B; Schmahmann S; Dacey E; Foss E
    Skeletal Radiol; 2015 Dec; 44(12):1825-31. PubMed ID: 26341245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal phosphaturic neoplasm in the maxillary sinus: a case report.
    Pedrazzoli M; Colletti G; Ferrari M; Rossetti G; Moneghini L; Autelitano L
    Int J Oral Maxillofac Surg; 2010 Oct; 39(10):1027-32. PubMed ID: 20483563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Right Leg that Troubled the Left Leg.
    B S; V A
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term use of burosumab for the treatment of tumor-induced osteomalacia.
    Crotti C; Zucchi F; Alfieri C; Caporali R; Varenna M
    Osteoporos Int; 2023 Jan; 34(1):201-206. PubMed ID: 35925260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
    Ni HJ; Clifton-Bligh R; Brzozowska MM
    Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
    [No Abstract]   [Full Text] [Related]  

  • 39. Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.
    Puthenveetil PJ; Hattab EM; Peacock M; Horn EM
    J Clin Neurosci; 2013 Aug; 20(8):1057-61. PubMed ID: 23618679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
    Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
    Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.